Gene Therapy

"Results from a Cleveland Clinic Phase 1, first-in-human clinical trial showed that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 safely reduced LDL (“bad”) cholesterol and triglycerides in people with lipid disorders resistant to current medications."https://newsroom.clevelandclinic.org/2025/11/08/cleveland-clinic-first-in-human-trial-of-crispr-gene-editing-therapy-shown-to-safely-lower-cholesterol-and-triglycerides?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4c92f5d78644b3ac5d5b4